Radiomic Analysis of Gd-EOB-DTPA-enhanced MRI Predicts Ki-67 Expression in Hepatocellular Carcinoma

Overview

Journal BMC Med Imaging

Publisher Biomed Central

Specialty Radiology

Date 2021 Jun 16

PMID 34130644

Citations 26

Authors

Yanfen Fan

Yixing Yu

Ximing Wang

Mengjie Hu

Chunhong Hu

Affiliations

Soon will be listed here.

Abstract

Background: Nuclear protein Ki-67 indicates the status of cell proliferation and has been regarded as an attractive biomarker for the prognosis of HCC. The aim of this study is to investigate which radiomics model derived from different sequences and phases of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI was superior to predict Ki-67 expression in hepatocellular carcinoma (HCC), then further to validate the optimal model for preoperative prediction of Ki-67 expression in HCC.

Methods: This retrospective study included 151 (training cohort: n = 103; validation cohort: n = 48) pathologically confirmed HCC patients. Radiomics features were extracted from the artery phase (AP), portal venous phase (PVP), hepatobiliary phase (HBP), and T2-weighted (T2W) images. A logistic regression with the least absolute shrinkage and selection operator (LASSO) regularization was used to select features to build a radiomics score (Rad-score). A final combined model including the optimal Rad-score and clinical risk factors was established. Receiver operating characteristic (ROC) curve analysis, Delong test and calibration curve were used to assess the predictive performance of the combined model. Decision cure analysis (DCA) was used to evaluate the clinical utility.

Results: The AP radiomics model with higher decision curve indicating added more net benefit, gave a better predictive performance than the HBP and T2W radiomic models. The combined model (AUC = 0.922 vs. 0.863) including AP Rad-score and serum AFP levels improved the predictive performance more than the AP radiomics model (AUC = 0.873 vs. 0.813) in the training and validation cohort. Calibration curve of the combined model showed a good agreement between the predicted and the actual probability. DCA of the validation cohort revealed that at a range threshold probability of 30-60%, the combined model added more net benefit compared with the AP radiomics model.

Conclusions: A combined model including AP Rad-score and serum AFP levels based on enhanced MRI can preoperatively predict Ki-67 expression in HCC.

Citing Articles

Three-dimensional MR elastography-based stiffness for assessing the status of Ki67 proliferation index and Cytokeratin-19 in hepatocellular carcinoma.

Zhang L, Xiao Y, Dong M, Li M, Chen H, Wang J Eur Radiol. 2025; .

PMID: 39964391 DOI: 10.1007/s00330-025-11375-w.

An MRI-based radiomics nomogram for preoperative prediction of Ki-67 index in nasopharyngeal carcinoma: a two-center study.

Wang Y, Zhang J, Li Q, Sun L, Zheng Y, Gao C Front Oncol. 2025; 14:1423304.

PMID: 39759139 PMC: 11695239. DOI: 10.3389/fonc.2024.1423304.

Preoperative prediction of Ki-67 expression in hepatocellular carcinoma by spectral imaging on dual-energy computed tomography (DECT).

Li C, Yue X, Chen S, Lin Y, Zhang Y, Liao L Quant Imaging Med Surg. 2024; 14(12):8402-8413.

PMID: 39698618 PMC: 11651942. DOI: 10.21037/qims-24-461.

Radiomics predicting immunohistochemical markers in primary hepatic carcinoma: Current status and challenges.

Yin Y, Zhang W, Chen Y, Zhang Y, Shen X Heliyon. 2024; 10(23):e40588.

PMID: 39660185 PMC: 11629216. DOI: 10.1016/j.heliyon.2024.e40588.

A predictive model based on radiomics, clinical features, and pathologic indicators for disease-free survival after liver transplantation for hepatocellular carcinoma: a 7-year retrospective study.

Xie H, Shi B, Fan J, Liu S, Ma Q, Dai J J Gastrointest Oncol. 2024; 15(5):2187-2200.

PMID: 39554565 PMC: 11565123. DOI: 10.21037/jgo-24-347.

References

Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S . Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg. 2014; 261(5):947-55. DOI: 10.1097/SLA.0000000000000710. View

Yang C, Zhang J, Ding M, Xu K, Li L, Mao L . Ki67 targeted strategies for cancer therapy. Clin Transl Oncol. 2017; 20(5):570-575. DOI: 10.1007/s12094-017-1774-3. View

Yang C, Su H, Liao X, Han C, Yu T, Zhu G . Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma. Cancer Manag Res. 2018; 10:679-696. PMC: 5901156. DOI: 10.2147/CMAR.S162595. View

Leijenaar R, Carvalho S, Velazquez E, van Elmpt W, Parmar C, Hoekstra O . Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability. Acta Oncol. 2013; 52(7):1391-7. PMC: 4533992. DOI: 10.3109/0284186X.2013.812798. View

Ye Z, Jiang H, Chen J, Liu X, Wei Y, Xia C . Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study. Chin J Cancer Res. 2019; 31(5):806-817. PMC: 6856708. DOI: 10.21147/j.issn.1000-9604.2019.05.10. View

Kumar V, Gu Y, Basu S, Berglund A, Eschrich S, Schabath M . Radiomics: the process and the challenges. Magn Reson Imaging. 2012; 30(9):1234-48. PMC: 3563280. DOI: 10.1016/j.mri.2012.06.010. View

Sofocleous C, Garg S, Petrovic L, Gonen M, Petre E, Klimstra D . Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies. Ann Surg Oncol. 2012; 19(13):4262-9. PMC: 4122119. DOI: 10.1245/s10434-012-2461-9. View

Aerts H, Velazquez E, Leijenaar R, Parmar C, Grossmann P, Carvalho S . Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014; 5:4006. PMC: 4059926. DOI: 10.1038/ncomms5006. View

Bakr S, Echegaray S, Shah R, Kamaya A, Louie J, Napel S . Noninvasive radiomics signature based on quantitative analysis of computed tomography images as a surrogate for microvascular invasion in hepatocellular carcinoma: a pilot study. J Med Imaging (Bellingham). 2017; 4(4):041303. PMC: 5565686. DOI: 10.1117/1.JMI.4.4.041303. View

10.

Peng J, Zhang J, Zhang Q, Xu Y, Zhou J, Liu L . A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma. Diagn Interv Radiol. 2018; 24(3):121-127. PMC: 5951199. DOI: 10.5152/dir.2018.17467. View

11.

Guzman G, Alagiozian-Angelova V, Layden-Almer J, Layden T, Testa G, Benedetti E . p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients. Mod Pathol. 2005; 18(11):1498-503. DOI: 10.1038/modpathol.3800458. View

12.

Li H, Xiao Y, Wang S, Li Y, Zhong X, Situ W . TWIST-VIBE five-arterial-phase technology decreases transient severe motion after bolus injection of Gd-EOB-DTPA. Clin Radiol. 2017; 72(9):800.e1-800.e6. DOI: 10.1016/j.crad.2017.03.013. View

13.

Mitsuhashi N, Kobayashi S, Doki T, Kimura F, Shimizu H, Yoshidome H . Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma. J Gastroenterol Hepatol. 2008; 23(7 Pt 2):e189-97. DOI: 10.1111/j.1440-1746.2008.05340.x. View

14.

van Griethuysen J, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V . Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res. 2017; 77(21):e104-e107. PMC: 5672828. DOI: 10.1158/0008-5472.CAN-17-0339. View

15.

Li Y, Yan C, Weng S, Shi Z, Sun H, Chen J . Texture analysis of multi-phase MRI images to detect expression of Ki67 in hepatocellular carcinoma. Clin Radiol. 2019; 74(10):813.e19-813.e27. DOI: 10.1016/j.crad.2019.06.024. View

16.

Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout R, Granton P . Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012; 48(4):441-6. PMC: 4533986. DOI: 10.1016/j.ejca.2011.11.036. View

17.

Huang X, Long L, Wei J, Li Y, Xia Y, Zuo P . Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis. J Cancer Res Clin Oncol. 2019; 145(12):2995-3003. PMC: 6861194. DOI: 10.1007/s00432-019-03062-3. View

18.

Murakami K, Kasajima A, Kawagishi N, Ohuchi N, Sasano H . Microvessel density in hepatocellular carcinoma: Prognostic significance and review of the previous published work. Hepatol Res. 2015; 45(12):1185-94. DOI: 10.1111/hepr.12487. View

19.

Schwier M, van Griethuysen J, Vangel M, Pieper S, Peled S, Tempany C . Repeatability of Multiparametric Prostate MRI Radiomics Features. Sci Rep. 2019; 9(1):9441. PMC: 6602944. DOI: 10.1038/s41598-019-45766-z. View

20.

Davenport M, Viglianti B, Al-Hawary M, Caoili E, Kaza R, Liu P . Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology. 2012; 266(2):452-61. DOI: 10.1148/radiol.12120826. View